Helicobacter pylori: Difference between revisions

From IDWiki
Helicobacter pylori
m (Text replacement - "[[Has Gram stain::" to "Stain::")
m (Text replacement - "[[Has urease test::" to "[[Urease test::")
Line 1: Line 1:
* Slow-growing Stain::Gram-negative]] microaerophilic [[Cellular shape::bacillus]] with a curve, gull-wing, or spiral appearance
* Slow-growing Stain::Gram-negative]] microaerophilic [[Cellular shape::bacillus]] with a curve, gull-wing, or spiral appearance
* [[Oxidase test::Oxidase-positive]] and [[Has urease test::urease-positive]]
* [[Oxidase test::Oxidase-positive]] and [[Urease test::urease-positive]]
* Major cause of peptic ulcer disease and gastric cancer
* Major cause of peptic ulcer disease and gastric cancer



Revision as of 01:56, 7 July 2020

  • Slow-growing Stain::Gram-negative]] microaerophilic bacillus with a curve, gull-wing, or spiral appearance
  • Oxidase-positive and urease-positive
  • Major cause of peptic ulcer disease and gastric cancer

References

  1. ^  M. Zamani, F. Ebrahimtabar, V. Zamani, W. H. Miller, R. Alizadeh‐Navaei, J. Shokri‐Shirvani, M. H. Derakhshan. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 2018;47(7):868-876. doi:10.1111/apt.14561.
  2. ^  G. Manes, A. Balzano, G. Iaquinto, C. Ricci, M. M. Piccirillo, N. Giardullo, A. Todisco, M. Lioniello, D. Vaira. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Alimentary Pharmacology & Therapeutics. 2001;15(1):73-79. doi:10.1046/j.1365-2036.2001.00907.x.